International Cannabis Weekly: 379

‘THE WAY IS CLEAR’: GERMAN MUNICIPALITIES GEAR UP FOR CANNABIS RESEARCH PILOTS

‘The way is clear’ for Germany’s growing list of municipalities, universities and cannabis businesses to launch model research projects into adult-use cannabis.

READ MORE  »

UK REGULATORS SIGNAL GOAL FOR ‘ZERO DETECTABLE THC’ IN CBD PRODUCTS

READ MORE »

NETHERLANDS’ COFFEESHOP EXPERIMENT TO ENTER NEW PHASE IN APRIL 2025

READ MORE »

• Portugal looking to become a global medical cannabis hub amidst growing demand.
• Barney’s Farm, Sensi Seeds, and ILGM announce their merger and IPO launch plans.
• Berlin reports drop in cannabis-related crime following recent legalisation developments.
• British Cannabis focuses on pioneering strain-specific sublingual oils for the UK market.
• Automation, compliance, and decontamination driving efficiency in scalable cannabis production globally.
• Poland’s medical cannabis crackdown sees a bump in sales, while Ireland’s cannabis future uncertain post-election.

FIND OUT MORE »

• New data supports use of Epidiolex for treating tuberous sclerosis complex patients.
• Texas proposes blanket THC ban in a move expected to decimate the hemp industry.
• GOP congressman and DC officials push to end the federal ban on marijuana sales.
• New York expects US$1 billion in cannabis sales, urging local purchases this holiday season.
• Canopy Growth completes acquisition of Acreage Holdings, expanding US cannabis footprint.
• US cannabis industry growth slows to a crawl amid price compression and delayed federal reform.

• Canada’s legalisation shifts consumers from illicit markets, with youth use remaining steady.
• Organigram acquires Motif for $90M, solidifying market leadership in Canadian cannabis.
• Tilray Canada launches THC beverage campaign with XMG and Mollo for holidays.
• Organigram becomes Canada’s largest cannabis company by market share after Motif acquisition.
• Only 5% of cannabis purchases in Canada now come from illicit sources.
• Xebra Brands extends warrants, reflecting strategic adjustments to its long-term business plans.

• Paraguay plans to raise THC limits for hemp production in order to boost industry growth.
• Espírito Santo develops cannabis production programs, boosting Brazil’s medicinal cannabis sector.
• Brazilian Ministry of Health to lead technical chamber on medicinal cannabis regulation.
• Buenos Aires advances legislation for medicinal cannabis use, supporting patient access and growth.

• Japan’s CBD industry receives first public investments after recent regulatory reforms.
• Cannim to feature on global TV series ‘High Science,’ promoting cannabis innovation.
• Leafio opens new distribution facility in Sydney, expanding reach across Australian markets.
• Rua Bioscience secures $12M funding despite challenging New Zealand medicinal cannabis market.

• South Africa’s R28 billion cannabis industry faces major regulatory changes and growth potential.
• Syqe Medical launches clinical trial of cannabis-based treatment for diabetes in African patients.